Record the frequency, severity (mild, moderate, severe), and duration of these symptoms, along with any precipitating factors or effective management strategies you discover
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Every formulation is developed with a focus on safety, efficacy, and patient well-being, ensuring reliable healthcare solutions for healthcare professionals and consumers across India.
The earlier phase 3 study tested two doses against placebo, and the results ran the opposite way to intuition: 0.05 mg/kg/day met the primary endpoint (16/35 responders, p=0.007) while the higher 0.10 mg/kg/day dose failed it (8/32, p=0.16) [3]
Often it's the preservative or base, not the GHK-Cu itself
.png.jpg)
